SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000904454-19-000276
Filing Date
2019-02-28
Accepted
2019-02-28 18:34:58
Documents
1
Period of Report
2019-02-26

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 4  
1 PRIMARY DOCUMENT edgar.xml 4 6283
  Complete submission text file 0000904454-19-000276.txt   7818
Mailing Address 75 PARK PLAZA 4TH FLOOR BOSTON MA 02116
Business Address 75 PARK PLAZA 4TH FLOOR BOSTON MA 02116 (617) 807-6600
Paratek Pharmaceuticals, Inc. (Issuer) CIK: 0001178711 (see all company filings)

IRS No.: 330960223 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1

Mailing Address 320 WAKARA WAY SALT LAKE CITY UT 84108
Business Address
Franson Timothy R (Reporting) CIK: 0001471650 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36066 | Film No.: 19645759